Recurrence prevention after venous thromboembolism: Apixaban beats rivaroxaban

被引：0
|
作者：
Ruchalla, Elke
机构：
来源：
PHLEBOLOGIE | 2025年 / 54卷 / 02期
关键词：
D O I：
10.1055/a-2479-8820
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：54 / 56
页数：3
相关论文
共 50 条
  • [21] Cost-effectiveness of rivaroxaban versus apixaban for the initial treatment of venous thromboembolism and extended prevention of recurrences in the UK
    Folkerts, Kerstin
    Broughton, Julie
    Sheikh, Usman
    Mckaig, Sasha
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (11) : 1179 - 1191
  • [22] Recurrence of venous thromboembolism and its prevention
    Prandoni, Paolo
    PHLEBOLYMPHOLOGY, 2008, 15 (01) : 3 - 11
  • [23] Bleeding rates of Veterans taking apixaban or rivaroxaban for atrial fibrillation or venous thromboembolism
    Howe, Zachary
    Naville-Cook, Chad
    Cole, Derek
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 47 (02) : 280 - 286
  • [24] Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism
    Simon Mantha
    Jack Ansell
    Journal of Thrombosis and Thrombolysis, 2015, 39 : 155 - 165
  • [25] Bleeding rates of Veterans taking apixaban or rivaroxaban for atrial fibrillation or venous thromboembolism
    Zachary Howe
    Chad Naville-Cook
    Derek Cole
    Journal of Thrombosis and Thrombolysis, 2019, 47 : 280 - 286
  • [26] Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism
    Mantha, Simon
    Ansell, Jack
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 39 (02) : 155 - 165
  • [27] Lupus Anticoagulant Testing in Patients Receiving Rivaroxaban or Apixaban for the Treatment of Venous Thromboembolism
    Kovacs, Matthew R.
    Lazo-Langner, Alejandro
    Louzada, Martha L.
    Kovacs, Michael J.
    BLOOD, 2016, 128 (22)
  • [28] Variation in Plasma Levels of Apixaban and Rivaroxaban in Clinical Routine Treatment of Venous Thromboembolism
    Reda, Sara
    Rudde, Eva
    Mueller, Jens
    Hamedani, Nasim Shahidi
    Oldenburg, Johannes
    Poetzsch, Bernd
    Ruehl, Heiko
    LIFE-BASEL, 2022, 12 (05):
  • [29] Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal
    Stevenson, M.
    Scope, A.
    Holmes, M.
    Rees, A.
    Kaltenthaler, E.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 43 - 48
  • [30] Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer-associated venous thromboembolism
    Wysokinski, Waldemar E.
    Houghton, Damon E.
    Casanegra, Ana I.
    Vlazny, Danielle T.
    Bott-Kitslaar, Dalene M.
    Froehling, David A.
    Hodge, David O.
    Peterson, Lisa G.
    Mcbane, Robert D.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (11) : 1185 - 1192
12345